Stockscreener 앱 받기
3.30
1.85%
0.06
Cytek Biosciences Inc 주식(CTKB)의 최신 뉴스
What analysts say about Cytek Biosciences Inc. stockExceptional ROI - Jammu Links News
Teacher Retirement System of Texas Decreases Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
How Cytek Biosciences Inc. stock performs during market volatilityDaily Swing Candidates - Newser
What makes Cytek Biosciences Inc. stock price move sharplyFree Expert-Led Investment Training - Newser
Why Cytek Biosciences Inc. stock attracts strong analyst attentionFree Stock Market Swing Trading Strategies - Newser
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by New York State Teachers Retirement System - Defense World
Wealth Enhancement Advisory Services LLC Invests $63,000 in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
MDxHealth names Michael Holder to board, CFO Ron Kalfus to depart - Investing.com
Research device company to relocate local office to Bellevue - The Business Journals
Cytek Biosciences (NASDAQ:CTKB) Trading Up 2.4% – Still a Buy? - Defense World
3 Promising Penny Stocks With Market Caps At Least $300M - Yahoo Finance
Cytek Biosciences Elects New Directors at Annual Meeting - TipRanks
Cytek Biosciences shareholders elect directors and approve auditor at annual meeting - Investing.com
Ratios Revealed: Decoding Cytek BioSciences Inc (CTKB)’s Financial Health - DWinneX
Flow Cytometer | Cytek Biosciences Inc. | Products - Photonics Spectra
Cytek Biosciences at Goldman Sachs Conference: Growth Amidst Challenges By Investing.com - Investing.com Canada
Transcript : Cytek Biosciences, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 02 - MarketScreener
Cytek Biosciences (CTKB) Faced Challenges from NIH Funding Reductions - Insider Monkey
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 22,433 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences Plunges 10.18% Amid Product Discontinuation Concerns - AInvest
Insider Buying: William Mccombe Acquires 35,000 Shares of Cytek Biosciences Inc (CTKB) - GuruFocus
Bank of America Corp DE Boosts Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences Leads Our Top 3 Penny Stock Selections - Yahoo Finance
ProShare Advisors LLC Has $235,000 Stock Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Sold by Jane Street Group LLC - Defense World
Ameriprise Financial Inc. Has $1.62 Million Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences, Inc. (CTKB) Elevates Cell Analysis with New Aurora Evo System - MSN
Optimizing Lab Efficiency with Cytek's Aurora Evo Flow Cytometer - Lab Manager
The Market Doesn't Like What It Sees From Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Revenues Yet As Shares Tumble 31% - simplywall.st
Cytek announces new full spectrum flow cytometer - SelectScience
Where are the Opportunities in (CTKB) - news.stocktradersdaily.com
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer - SINA HONG KONG LIMITED
Cytek® Biosciences Is Setting the New Standard for Full - GlobeNewswire
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer - GlobeNewswire Inc.
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by Millennium Management LLC - Defense World
Deutsche Bank AG Acquires 36,542 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences (NASDAQ:CTKB) Given New $7.00 Price Target at Morgan Stanley - Defense World
Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewswire
Cytek Management Sets Key Investor Presentation at Goldman Sachs Healthcare Conference - Stock Titan
Beyond The Numbers: 4 Analysts Discuss Cytek Biosciences Stock - Benzinga
Cytek Biosciences (CTKB) Price Target Reduced by Morgan Stanley - GuruFocus
Cytek Biosciences (CTKB) Price Target Reduced by Morgan Stanley | CTKB Stock News - GuruFocus
Cytek Biosciences (CTKB) Price Target Revised by Morgan Stanley - GuruFocus
Cytek Biosciences (CTKB) Price Target Revised by Morgan Stanley | CTKB Stock News - GuruFocus
Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail
Institutional investors may adopt severe steps after Cytek Biosciences, Inc.'s (NASDAQ:CTKB) latest 10% drop adds to a year losses - simplywall.st
Cytek Biosciences Introduces a New High-Dimensional Sorter - Lab Manager
Cytek Biosciences stock hits 52-week low at $2.5 amid market challenges - Investing.com Canada
1.67%
0.94%
자본화:
|
볼륨(24시간):